Latest 8-K filings

OPKO Health has amended its Note Purchase Agreement to issue an additional $125 million in senior secured notes, maturing in 2044, backed by royalty interests.

Cabot Corporation has announced the pricing of a $350 million offering of 4.950% notes due 2029, with an expected closing date of August 21, 2026.

Rhinebeck Bancorp, Inc. has terminated its Executive Long-Term Incentive and Retention Plan, with all participant accounts fully vested but distributions delayed.

Applied Industrial Technologies announced the election of Pamela J. Tomczik to its Board of Directors and the upcoming retirement of Peter C. Wallace.

Corvex, Inc. announced its second quarter 2026 financial results, reporting $3.8 million in revenue and a net loss of $12.8 million, while highlighting a significant increase in contracted annualized recurring revenue for its AI computing platform.

Invesco Mortgage Capital Inc. announced its August dividend and provided preliminary July 31, 2026 financial data, including portfolio composition, leverage, and liquidity.

RadNet, Inc. has filed a prospectus supplement to register for resale up to 34,069 shares of its common stock by certain See-Mode Sellers, stemming from a June 2025 Share Purchase Agreement.

Elme Communities has completed the sale of its Elme Bethesda property for $58.0 million, as part of its ongoing liquidation and asset disposition strategy.

BioRestorative Therapies, Inc. has immediately suspended all orders and shipments of its biocosmeceutical product lines, ExoCR and BioX, pending a business review and regulatory assessment.

Enveric Biosciences reported second quarter 2026 financial results and provided a corporate update, highlighting advancements in its EB-003 development program and securing new patents.

Reeds, Inc. received a deficiency notice from NYSE American for failing to meet continued listing standards regarding stockholder equity, though a compliance plan has been accepted.

Barfresh Food Group reported a 190% year-over-year revenue increase to $4.7 million in Q2 2026, driven by the Arps Dairy acquisition, but revised full-year guidance downwards due to production inefficiencies.

Greenlane Holdings reported a significant net loss and a sharp year-over-year revenue decrease in its second quarter 2026 results, while its digital asset holdings saw a substantial decline in fair value.

VICI Properties L.P. has completed the offering of $900 million in 5.400% Senior Notes due 2031 and $850 million in 5.750% Senior Notes due 2036, intending to use proceeds to repay existing debt.

Martin Marietta Materials announces the issuance of $5.5 billion in senior notes across five series to fund its acquisition of Lhoist North America, Inc.

Vycor Medical, Inc. announced financial results for the three and six months ended June 30, 2026, showing a decrease in revenue and operating profit for its Vycor Medical division.

SES AI Corporation received notice from the NYSE of its intent to delist the company's public warrants due to abnormally low selling prices.

NewAmsterdam Pharma Company N.V. amends prior filing to detail separation and advisory agreements for former COO Douglas Kling.

LeonaBio announced its second quarter 2026 financial results, highlighting progress in its Phase 3 ELAINE-3 trial for lasofoxifene and providing a business update.

SkinHealth Systems Inc. announced the resignation of its Chief Operations, Quality and Technology Officer, Sheri Lewis, effective August 28, 2026.

O'Reilly Automotive, Inc. has announced the issuance of $1.6 billion in aggregate principal amount of new senior notes across three tranches maturing in 2029, 2031, and 2037.

Prestige Consumer Healthcare Inc. announced the retirement of Senior Vice President, Operations, Jeffrey Zerillo, effective August 14, 2026.

Carlyle Credit Income Fund announced its unaudited net asset value per common share as of July 31, 2026, was $3.24.

CSP Inc. announced its third quarter fiscal year 2026 financial results, reporting a decrease in sales and an increased net loss, though highlighting a strong backlog and optimism for fiscal year 2027.

Lifeloc Technologies announced second quarter 2026 results, showing a 10% increase in net revenue to $2.445 million and improved gross margins, though the company reported a net loss of $134,000.

BioForce NanoScience Holdings, Inc. has announced several key appointments to its leadership and advisory teams, including a new General Counsel, a new Director, and two Advisory Board members, effective May and June 2026.

HCW Biologics Inc. announced its second quarter 2026 financial results, highlighting positive preliminary data for its HCW9302 drug candidate and significant revenue growth, while also addressing ongoing financial challenges.

Reading International announced robust second quarter 2026 results, showcasing significant revenue and income growth driven by strong cinema operations and favorable foreign exchange rates.

AppTech Payments Corp. has entered into a $500,000 promissory note with the Suzanne D. Lord Spousal Estate Reduction Trust for working capital, with a 9.0% interest rate and a 90-day maturity.

Emmaus Life Sciences announces a 124% surge in Q2 2026 net revenues, primarily from a new license agreement, alongside reduced operating expenses and a return to profitability.